Closed · CDC-RFA-PS22-2210 · CFDA 93.939 · Discretionary
Mass Mailing of HIV Self-Tests to Persons Disproportionately Affected by HIV in the U.S.
Federal grant opportunity posted by Centers for Disease Control - NCHHSTP, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- July 11, 2022
- Close date
- 1
- Expected awards
The verdict
Mass Mailing of HIV Self-Tests to Persons Disproportionately Affected by HIV in the U.S. is a closed discretionary listing from Centers for Disease Control - NCHHSTP that offered Varies by applicant across 1 expected award. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 1
- expected award
- 93.939
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Mass Mailing of HIV Self-Tests to Persons Disproportionately Affected by HIV in the U.S. - is cataloged under number CDC-RFA-PS22-2210 and tied to CFDA assistance listing 93.939, posted by Centers for Disease Control - NCHHSTP. Grants.gov currently shows the opportunity as closed, first posted on May 26, 2022. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is Varies by applicant. The agency has projected $41.5 million in total estimated funding for this announcement. It expects to issue 1 award. If the agency funds the expected 1 award from the $41.5 million estimated pool, the average award works out to roughly $41.5 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on July 11, 2022. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
July 11, 2022
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date in grants.gov ONLY.
Posted
May 26, 2022
Est. Total Funding
$41,500,000
Expected Awards
1
Instrument
Cooperative Agreement
Description
In the United States as of 2019, an estimated 13% of persons with HIV were unaware of their HIV infection. This group accounts for a disproportionate number of new infections each year. Gay, bisexual, and other men who have sex with men (MSM) accounted for approximately 70% of new infections annually in the U.S. Traditional healthcare venues and their access barriers often result in inadequate engagement with HIV testing, treatment, and prevention services. Socioeconomic factors, cultural norms, stigma, homophobia, and discrimination are associated with reduced access to HIV testing, prevention, and treatment. The long-standing and intersecting inequities in access to services both increase HIV infection rates and hinder access to testing services in traditional clinical or community settings. Black or African American (hereafter referred to as Black) and Hispanic/Latino (hereafter referred to as Hispanic) MSM are more severely affected by HIV than other populations. In 2019, Black and Hispanic MSM accounted for 37% and 32% of MSM diagnosed with HIV, respectively. Transgender women (TGW) are also disproportionately affected by HIV, and racial and ethnic disparities are also seen among TGW. National HIV Behavioral Surveillance data (2019-2020) reported that 62% of Black TGW and 35% of Hispanic TGW were living with HIV compared to 17% of White TGW. In 2019, 54% of infections among women were in Black women. A recently completed pilot project that distributed 100,000 HIVSTs with focus on these population groups found success distributing tests to all groups by mail and that overall, 26% of those who ordered a test reported they have never previously tested for HIV. (CDC Contract# 75D30120C09658). This project supports the first pillar of EHE by increasing the percentage of persons diagnosed with HIV. This program will provide HIVSTs to communities most affected by HIV. Effective HIV prevention services, including the opportunity to more frequently test for HIV, are needed to reach these populations. This program will provide free HIVSTs and resources for accessing HIV preventive services to people in communities most affected by HIV. Most Americans are using the internet for a variety of purposes. Using tailored advertising materials and strategies developed by CDC, web-based information about HIV testing, prevention and treatment services will be provided. This online approach is effective in increasing awareness of HIV infection outside of traditional brick-and-mortar testing sites. This has been demonstrated by recent research on the distribution of HIVSTs to MSM (Contract #200-2011-41989), and the pilot national HIVST distribution program. The direct-to-consumer distribution of HIVSTs represents a timely approach and complements existing local and national HIV testing efforts. Distributing HIVSTs can further leverage existing public health prevention efforts to reduce the number of persons with undiagnosed infection, and provide resources to help access treatment and prevention services. These efforts will contribute to the goals of reducing HIV transmission and preventing HIV disease progression. The CDC Let’s Stop HIV Together campaign (Together) is a comprehensive HIV prevention, testing, treatment and stigma reduction campaign. This program will be conducted with substantial involvement from CDC. Close collaboration with CDC will ensure that populations most in need of HIVSTs are reached through advertising, are able to order HIVSTs, and receive messages regarding HIV prevention and treatment.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25, 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Kevin Delaney, MPH, Phd HRBNOFO@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |